Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Analyst Ratings

Analyst Ratings

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Citigroup Maintains Buy on Amylyx Pharma, Raises Price Target to $37

By Benzinga Newsdesk
July 6, 7:56 AM
Citigroup analyst Neena Bitritto-Garg maintains Amylyx Pharma (NASDAQ:AMLX) with a Buy and raises the price target from $33 to $37.

AMLX

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Morgan Stanley Maintains Equal-Weight on Brighthouse Finl, Lowers Price Target to $54

By Benzinga Newsdesk
July 6, 7:54 AM
Morgan Stanley analyst Nigel Dally maintains Brighthouse Finl (NASDAQ:BHF) with a Equal-Weight and lowers the price target from $62 to $54.

BHF

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Barclays Maintains Overweight on Valero Energy, Raises Price Target to $133

By Benzinga Newsdesk
July 6, 7:53 AM
Barclays analyst Theresa Chen maintains Valero Energy (NYSE:VLO) with a Overweight and raises the price target from $120 to $133.

VLO

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Morgan Stanley Maintains Equal-Weight on Bank of New York Mellon, Lowers Price Target to $45

By Benzinga Newsdesk
July 6, 7:51 AM
Morgan Stanley analyst Betsy Graseck maintains Bank of New York Mellon (NYSE:BK) with a Equal-Weight and lowers the price target from $53 to $45.

BK

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Morgan Stanley Maintains Equal-Weight on Ameriprise Financial, Lowers Price Target to $255

By Benzinga Newsdesk
July 6, 7:49 AM
Morgan Stanley analyst Nigel Dally maintains Ameriprise Financial (NYSE:AMP) with a Equal-Weight and lowers the price target from $330 to $255.

AMP

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Morgan Stanley Maintains Equal-Weight on American Equity Inv, Lowers Price Target to $40

By Benzinga Newsdesk
July 6, 7:47 AM
Morgan Stanley analyst Nigel Dally maintains American Equity Inv (NYSE:AEL) with a Equal-Weight and lowers the price target from $41 to $40.

AEL

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Barclays Maintains Overweight on Copa Holdings, Lowers Price Target to $85

By Benzinga Newsdesk
July 6, 7:43 AM
Barclays analyst Pablo Monsivais maintains Copa Holdings (NYSE:CPA) with a Overweight and lowers the price target from $96 to $85.

CPA

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Barclays Maintains Overweight on Phillips 66, Raises Price Target to $113

By Benzinga Newsdesk
July 6, 7:41 AM
Barclays analyst Theresa Chen maintains Phillips 66 (NYSE:PSX) with a Overweight and raises the price target from $95 to $113.

PSX

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Credit Suisse Maintains Neutral on CME Group, Lowers Price Target to $233

By Benzinga Newsdesk
July 6, 7:39 AM
Credit Suisse analyst Gautam Sawant maintains CME Group (NASDAQ:CME) with a Neutral and lowers the price target from $242 to $233.

CME

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Citigroup Maintains Buy on Liberty Energy, Raises Price Target to $24

By Benzinga Newsdesk
July 6, 7:35 AM
Citigroup analyst Scott Gruber maintains Liberty Energy (NYSE:LBRT) with a Buy and raises the price target from $22 to $24.

LBRT

Posts pagination

Previous 1 … 4,400 4,401 4,402 … 4,420 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service